Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.180
-0.040 (-3.28%)
Jun 5, 2026, 4:00 PM EDT - Market closed
Entera Bio Market Cap
Entera Bio has a market cap or net worth of $58.09 million as of June 5, 2026. Its market cap has decreased by -33.09% in one year.
Market Cap
58.09M
Enterprise Value
54.40M
1-Year Change
-33.09%
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since June 28, 2018, Entera Bio's market cap has decreased from $71.77M to $58.09M, a decrease of -19.07%. That is a compound annual growth rate of -2.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 58.09M | -34.71% |
| Dec 31, 2025 | 88.96M | 13.93% |
| Dec 31, 2024 | 78.08M | 351.66% |
| Dec 29, 2023 | 17.29M | -17.80% |
| Dec 30, 2022 | 21.03M | -74.04% |
| Dec 31, 2021 | 81.03M | 308.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MediciNova | 64.97M |
| Cingulate | 64.79M |
| Acrivon Therapeutics | 64.63M |
| MiNK Therapeutics | 63.57M |
| TScan Therapeutics | 63.52M |
| PMV Pharmaceuticals | 61.86M |
| ImageneBio | 61.47M |
| Edesa Biotech | 60.96M |